![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 39, 37658-37663, September 26, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

||
From the
The Walter and Eliza Hall Institute of Medical Research, and ¶Department of Pathology, The University of Melbourne, Melbourne 3050, Australia
Escape from the host erythrocyte by the invasive stage of the malaria parasite Plasmodium falciparum is a fundamental step in the pathogenesis of malaria of which little is known. Upon merozoite invasion of the host cell, the parasite becomes enclosed within a parasitophorous vacuole, the compartment in which the parasite undergoes growth followed by asexual division to produce 1632 daughter merozoites. These daughter cells are released upon parasitophorous vacuole and erythrocyte membrane rupture. To examine the process of merozoite release, we used P. falciparum lines expressing green fluorescent protein-chimeric proteins targeted to the compartments from which merozoites must exit: the parasitophorous vacuole and the host erythrocyte cytosol. This allowed visualization of merozoite release in live parasites. Herein we provide the first evidence in live, untreated cells that merozoite release involves a primary rupture of the parasitophorous vacuole membrane followed by a secondary rupture of the erythrocyte plasma membrane. We have confirmed, with the use of immunoelectron microscopy, that parasitophorous vacuole membrane rupture occurs before erythrocyte plasma membrane rupture in untransfected wild-type parasites. We have also demonstrated selective inhibition of each step in this two-step process of exit using different protease inhibitors, implicating the involvement of distinct proteases in each of these steps. This will facilitate the identification of the parasite and host molecules involved in merozoite release.
Received for publication, May 19, 2003 , and in revised form, July 10, 2003.
* This work was supported by Grant R01-AI44008 from the National Institutes of Health and a grant from the National Health and Medical Research Council of Australia. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Supported by an Australian Postgraduate Research Award.
|| Supported by an International Research Fellowship from the Howard Hughes Medical Institute. To whom correspondence should be addressed: 1G Royal Parade, Melbourne 3050, Australia. Tel.: 61-3-93452555; Fax: 61-3-93470852; E-mail: cowman{at}wehi.edu.au.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
W. D. Fairlie, T. P. Spurck, J. E. McCoubrie, P. R. Gilson, S. K. Miller, G. I. McFadden, R. Malby, B. S. Crabb, and A. N. Hodder Inhibition of Malaria Parasite Development by a Cyclic Peptide That Targets the Vital Parasite Protein SERA5 Infect. Immun., September 1, 2008; 76(9): 4332 - 4344. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lisk, M. Pain, I. Y. Gluzman, S. Kambhampati, T. Furuya, X.-z. Su, M. P. Fay, D. E. Goldberg, and S. A. Desai Changes in the Plasmodial Surface Anion Channel Reduce Leupeptin Uptake and Can Confer Drug Resistance in Plasmodium falciparum-Infected Erythrocytes Antimicrob. Agents Chemother., July 1, 2008; 52(7): 2346 - 2354. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Teuscher, J. Lowther, T. S. Skinner-Adams, T. Spielmann, M. W. A. Dixon, C. M. Stack, S. Donnelly, A. Mucha, P. Kafarski, S. Vassiliou, et al. The M18 Aspartyl Aminopeptidase of the Human Malaria Parasite Plasmodium falciparum J. Biol. Chem., October 19, 2007; 282(42): 30817 - 30826. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Eksi, B. Czesny, G.-J. van Gemert, R. W. Sauerwein, W. Eling, and K. C. Williamson Inhibition of Plasmodium falciparum Oocyst Production by Membrane-Permeant Cysteine Protease Inhibitor E64d Antimicrob. Agents Chemother., March 1, 2007; 51(3): 1064 - 1070. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S.I. Aly and K. Matuschewski A malarial cysteine protease is necessary for Plasmodium sporozoite egress from oocysts J. Exp. Med., July 18, 2005; 202(2): 225 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Desai, A. Alkhalil, M. Kang, U. Ashfaq, and M.-L. Nguyen Plasmodial Surface Anion Channel-independent Phloridzin Resistance in Plasmodium falciparum J. Biol. Chem., April 29, 2005; 280(17): 16861 - 16867. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Klemba, I. Gluzman, and D. E. Goldberg A Plasmodium falciparum Dipeptidyl Aminopeptidase I Participates in Vacuolar Hemoglobin Degradation J. Biol. Chem., October 8, 2004; 279(41): 43000 - 43007. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Sijwali, K. Kato, K. B. Seydel, J. Gut, J. Lehman, M. Klemba, D. E. Goldberg, L. H. Miller, and P. J. Rosenthal Plasmodium falciparum cysteine protease falcipain-1 is not essential in erythrocytic stage malaria parasites PNAS, June 8, 2004; 101(23): 8721 - 8726. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |